EmERGE is a project funded by the European Union’s Horizon 2020 Researcher and Innovation Programme. It will develop a mHealth platform to enable self-management of HIV in patients with stable disease.
The platform will build upon and integrate the existing mHealth solutions operated by pioneering healthcare providers in the UK and Spain and apply a rigorous co-design approach to ensure patient and clinician input to the solution. The platform will provide users with web based and mobile device applications which interface securely with relevant medical data and facilitate remote access to key healthcare providers.
The Brighton and Sussex University Hospitals Trust will co-ordinate the study with University of Brighton leading on the socio technical evaluation of the EmERGE platform.
The EmERGE Project has received funding from the European Union's Horizon 2020. Research and Innovation Programme under Grant Agreement Number 643736.
The project will run from May 2015 until May 2020.
Based on prior work showing a high uptake rate and use of mHealth in HIV patient populations, EmERGE aims to demonstrate the benefits to patients and simultaneous increases in cost-effectiveness for healthcare providers by reducing face-to-face consultations, estimated at 6000 saved per year within this study alone.
Patient reported outcomes will be agreed and used in the assessment and development of the system which also aims to increase adherence and enable frailty to be reported using mHealth technology. Innovation will be given priority from the beginning by developing new business models of care provision, targeting key stakeholders in the EU health provider sector, including policymakers and clinicians, while eliciting demand from patients to highlight and initiate the widespread implementation and compensation of mHealth solutions within the timeframe of the project.
For the socio technical evaluation of the EmERGE platform we will:
Guidelines and policy briefs will be produced to evidence the benefits and disseminate the lessons learned to support the uptake of mHealth for self-management of other chronic diseases.
Professor Flis Henwood
Dr Mary Darking
Dr Benjamin Marent
To follow on completion of the project.
University of Sussex, UK
European AIDS Treatment Group (EATG) - Germany
Prins Leopold Instituut voor Tropische Geneeskunde (ITM ) - Belgium
Podmedics Limited (POD) - UK
Fundacio Privada Clinic Per A La Recerca Biomedica (Fcrb ) - Spain
Brighton And Sussex University Hospitals Nhs Trust (Bsuht ) – United Kingdom
Centro Hospitalar De Lisboa Central, Epe - Portugal
Klinika Za Infektivne Bolesti Dr. Fran Mihaljevic - Croatia
Npms-Hhc Cic (Npms ) - United Kingdom
Universidad Politecnica De Madrid - Spain
Mhealth Futures Ltd (Mhf ) - United Kingdom